Oxford study indicates AstraZeneca effective against Brazil variant, source says

Preliminary data from a study conducted at the University of Oxford indicates that the Covid-19 vaccine developed by AstraZeneca PLC is effective against the P1, or Brazilian, variant, a source with knowledge of the study told Reuters on Friday. The data indicates that the vaccine will not need to be modified in order to protect against the variant, which is believed to have